The new Butantan Dengue Vaccine

被引：0
|
作者：
Passi, Gouri Rao [1 ]
机构：
[1] Choithram Hosp & Res Ctr, Dept Pediat, Indore, Madhya Pradesh, India
来源：
INDIAN PEDIATRICS | 2024年 / 61卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：394 / 394
页数：1
相关论文
共 50 条
  • [31] Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort
    Silveira, Cassia G. T.
    Magnani, Diogo M.
    Costa, Priscilla R.
    Avelino-Silva, Vivian I.
    Ricciardi, Michael J.
    Timenetsky, Maria do Carmo S. T.
    Goulart, Raphaella
    Correia, Carolina A.
    Marmorato, Mariana P.
    Ferrari, Lilian
    Nakagawa, Zelinda B.
    Tomiyama, Claudia
    Tomiyama, Helena
    Kalil, Jorge
    Palacios, Ricardo
    Precioso, Alexander R.
    Watkins, David I.
    Kallas, Esper G.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Cost of production of live attenuated dengue vaccines: A case study of the Institut Butantan, Sao Paulo, Brazil
    Mahoney, R. T.
    Francis, D. P.
    Frazatti-Gallina, N. M.
    Precioso, A. R.
    Raw, I.
    Watler, P.
    Whitehead, P.
    Whitehead, S. S.
    VACCINE, 2012, 30 (32) : 4892 - 4896
  • [33] TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden
    Wilder-Smith, Annelies
    LANCET GLOBAL HEALTH, 2024, 12 (02): : e179 - e180
  • [34] VIRULENCE OF A LIVE DENGUE VIRUS-VACCINE CANDIDATE - A POSSIBLE NEW MARKER OF DENGUE VIRUS ATTENUATION
    INNIS, BL
    ECKELS, KH
    KRAISELBURD, E
    DUBOIS, DR
    MEADORS, GF
    GUBLER, DJ
    BURKE, DS
    BANCROFT, WH
    JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (04): : 876 - 880
  • [35] Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
    Lesley J. Scott
    Drugs, 2016, 76 : 1301 - 1312
  • [36] Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
    Sridhar, S.
    Luedtke, A.
    Langevin, E.
    Zhu, M.
    Bonaparte, M.
    Machabert, T.
    Savarino, S.
    Zambrano, B.
    Moureau, A.
    Khromava, A.
    Moodie, Z.
    Westling, T.
    Mascarenas, C.
    Frago, C.
    Cortes, M.
    Chansinghakul, D.
    Noriega, F.
    Bouckenooghe, A.
    Chen, J.
    Ng, S. -P.
    Gilbert, P. B.
    Gurunathan, S.
    DiazGranados, C. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 327 - 340
  • [37] Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
    Scott, Lesley J.
    DRUGS, 2016, 76 (13) : 1301 - 1312
  • [38] The dengue vaccine pipeline: Implications for the future of dengue control
    Schwartz, Lauren M.
    Halloran, M. Elizabeth
    Durbin, Anna P.
    Longini, Ira M., Jr.
    VACCINE, 2015, 33 (29) : 3293 - 3298
  • [39] Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Institute Butantan
    Koike, Marcelo E.
    Gattas, Vera L.
    Lucchesi, Maria Beatriz B.
    Moura de Oliveira, Mayra M.
    Vanni, Tazio
    Thome, Beatriz da C.
    Menang, Olga
    Socquet, Muriel
    Precioso, Alexander R.
    VACCINE, 2019, 37 (52) : 7560 - 7565
  • [40] Mexico approves dengue vaccine
    不详
    SCIENCE, 2015, 350 (6267) : 1446 - 1447
12345